Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.
Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.
复制标题
咨询师对在药物滥用治疗计划中采用戒烟药物的了解。
DOI：
10.1111/j.1521-0391.2010.00095.x
复制
发表时间：
2011
期刊：
影响因子：
--
通讯作者：
Eby,LillianT
中科院分区：
文献类型：
--
作者：
Rothrauff,TanjaC;Eby,LillianT
本研究评估了咨询师对采用循证戒烟药物（TCM）的知识-伐尼克兰，安非他酮和五种尼古丁替代疗法（NRT）-以及在不同物质滥用治疗环境中采用的预测因素。我们使用了来自26个项目的658名咨询师的治疗服务管理有效关系（MERITS I）数据。16%的咨询师报告采用伐尼克兰，11%采用安非他酮，27%采用NRT。采用所有类型的中医药的知识更有可能由在治疗项目中工作的顾问报告，这些治疗项目较少坚持12步指导和限制员工户外吸烟。还确定了伐尼克兰和NRT的几个额外的独特预测因子。(Am J Addict 2010;00：1-7）
This study assessed counselors’ knowledge of the adoption of evidence‐based tobacco cessation medications (TCMs)—varenicline, bupropion, and five nicotine replacement therapies (NRTs)—and predictors of adoption in diverse substance abuse treatment settings. We used Managing Effective Relationships in Treatment Services (MERITS I) data from 658 counselors working in 26 programs. Adoption of varenicline was reported by 16% of counselors, bupropion by 11%, and NRTs by 27%. Knowledge of the adoption of all types of TCMs was more likely to be reported by counselors who worked in treatment programs that adhered less to a 12‐step orientation and restricted outdoor smoking for employees. Several additional unique predictors of varenicline and NRTs were identified.(Am J Addict 2010;00: 1–7)